Indian Stock Market Indices Close Positively; Brokerages Recommend Stocks for Potential Upside

Stock recommendations are expert suggestions designed to guide investors in making informed decisions about buying, selling, or holding stocks. These recommendations are typically based on thorough market analysis, company performance, and other relevant factors. The Benchmark Indices concluded Friday’s trading session positively, with the Sensex rising by 166.49 points, or 0.21 percent, ending the day at 78,094.64. Meanwhile, the Nifty 50 index rose by 66.45 points, equivalent to a rise of 0.27 percent, and closed in the green at 24,383.60. Below are stocks that brokerages have recommended for a potential upside of up to 54 percent. Chalet Hotels Ltd. is one of the top hotel companies in India, having developed, owned, and managed luxury hotels. Some of the internationally known hotel chains it collaborates with include Marriott and Hyatt. Chalet Hotels Ltd. also invests in commercial as well as retail space development. , one of the prominent Indian brokerage firms, has recommended a “Buy” call on the stock with a target price of Rs. 1,250 per share, indicating an upside potential of percent from the day’s close price of Rs. 810.00. IRB Infrastructure Developers Ltd. is one of the largest infrastructure firms in India involved in road and highway infrastructure development. Its working structure includes BOT and HAM projects. The firm also handles tolling operations and asset management related to infrastructure. , one of the prominent Indian brokerage firms, has recommended a “Buy” call on the stock with a target price of Rs. 29 per share, indicating an upside potential of percent from the day’s close price of Rs. 20.00. TBO Tek Ltd. is a globally recognized travel distribution system connecting travel suppliers to buyers like travel agencies. It offers booking services for hotels, flights, rental cars, cruises, and various other travel-related services. TBO Tek Ltd. operates in several countries, thus making travel commerce easy on a global level. , one of the prominent Indian brokerage firms, has recommended a “Buy” call on the stock with a target price of Rs. 2,200 per share, indicating an upside potential of percent from the day’s close price of Rs. 1534.90. Pine Labs Ltd . is a fintech company that provides digital payment and merchant commerce solutions. These include payment terminals, online payment gateways, buy now pay later services, and loyalty programs. Pine Labs serves merchants in Asia and helps them simplify the process of payments. one of the prominent Indian brokerage firms, has recommended a “Buy” call on the stock with a target price of Rs. 210 per share, indicating an upside potential of percent from the day’s close price of Rs. 139.00. Bajaj Housing Finance Limited is a subsidiary of Bajaj Finance Limited offering mortgage loans, property loans, and developer loans. This corporation offers affordable housing finance solutions that are customer-oriented, with quick approval processes and competitive interest rates, and digital services to promote the growth of the real estate sector in India. one of the prominent Indian brokerage firms, has recommended a “Buy” call on the stock with a target price of Rs. 125 per share, indicating an upside potential of percent from the day’s close price of Rs. 86.03. Adani Ports & Special Economic Zone Ltd. (APSEZ) is the biggest private port operator of India. APSEZ is involved in developing and operating various projects, including ports, logistics parks, warehousing, and transport infrastructure. APSEZ is an important player in ensuring trade both domestically and internationally through its logistics and maritime services in India. one of the prominent Indian brokerage firms, has recommended a “Buy” call on the stock with a target price of Rs. 2,130 per share, indicating an upside potential of percent from the day’s close price of Rs. 1699.50. Mankind Pharma Limited is among the topmost pharmaceutical companies of India that manufacture medicines under prescription, OTC health care products, and consumer well-being products. The organization has strong domestic operations along with international expansion. It mainly concentrates on affordable healthcare, innovation, quality manufacturing, and a wide distribution network. one of the prominent Indian brokerage firms, has recommended a “Buy” call on the stock with a target price of Rs. 2975 per share, indicating an upside potential of percent from the day’s close price of Rs. 2469.90. Sridhar is a NISM-certified Research Analyst with an MBA in Finance and with over 3+ years of experience as a Financial Analyst, possessing strong expertise in both fundamental and technical analysis. Specialises in equity research, company and sector evaluation, IPO analysis, and tracking market trends to produce clear, investor-friendly insights.